Zymeworks, Inc. (ZYME)
23.29
-0.52
(-2.18%)
USD |
NASDAQ |
Feb 27, 16:00
23.29
0.00 (0.00%)
After-Hours: 07:38
Zymeworks Research and Development Expense (Annual) : 134.62M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Vertex Pharmaceuticals, Inc. | 3.754B |
| Krystal Biotech, Inc. | 52.32M |
| Scholar Rock Holding Corp. | 182.61M |
| Stoke Therapeutics, Inc. | 86.96M |